Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Trump Threatens Bombardier U.S. Sales Ban
Australia Plans New Rules Giving Users Control Over Social Media Feeds
Enflame Shares Surge 200% in Shanghai AI Chip Debut
Spire Healthcare Shares Jump on £1.03 Billion Takeover Deal
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit
Asian Currencies Subdued as Yen Weakens Ahead of Fed, BOJ Decisions
German Inflation Accelerates to 2.9% in August
Asian Stocks Slide as Oil Surge Fuels Rate Hike Fears
Asian Stocks Fall as Oil Tops $100, Yields Rise
Gulf Ministers to Meet Iran in Oman Over Hormuz Shipping Deal
Japan Producer Inflation Eases to 7.6% in August
Gold Prices Steady Ahead of U.S. Inflation Data and Fed Decision
Kioxia Rules Out SK Hynix Manufacturing Partnership
Huawei, Chinese AI Chipmakers Raise Prices as HBM Shortage Bites
Longsys Raises $903 Million in Hong Kong IPO as Shares Debut Flat
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe
Treasury Buyback Fails to Cool Long-Term Yields 



